The Report covers cases involving a variety of prescription drugs, vaccines, implants and devices. Duract, Parlodel, Zoloft, Accutane, fen-phen, Rezulin, Propulsid, dietary supplements and blood products are among the topics tracked. Medical devices covered include heart catheters, Sulzer hip implants, breast implants, heart valves, intraocular lenses, jaw implants, joint replacements, latex gloves, pacemakers, pedicle screws, penile implants, and surgical lasers. Published twice monthly.
Featured Stories
Generic Reglan Makers Lack Duty To Change Labels; Warning Claims Preempted
MINNEAPOLIS — Two generic Reglan manufacturers are preempted by federal law from unilaterally changing their warning labels, have no duty to make changes and cannot issue dear doctor warning letters, a federal judge ruled June 17 in granting dismissal in an injury case (Gladys Mensing v. Wyeth, Inc., et al., No. 07-3919, D. Minn.). . . .
Generic Ibuprofen Warning Claim Found Preempted In California
SAN JOSE, Calif. — A California federal judge on June 13 ruled that the failure-to-warn claims of a child who needed a liver transplant and lost parts of his fingers and toes after taking generic ibuprofen are preempted by federal law (Margarita Gaeta, et al. v. Perrigo Pharmaceuticals Company, et al., No. 05-4115, N.D. Calif., San Jose Div.). . . .